Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose for fatigue in iron-deficient non-anaemic women
2009-017737-21Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose arm with Placebo arm (2 arms). Primary endpoint: Primary responder rate for fatigue improvement. Started Mar 2010; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2009-017737-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017737-21.